Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD) by Hwang, Ho Sik et al.
Meibocyte Differentiation and Renewal: Insights into Novel Mechanisms of Meibomian 
Gland Dysfunction (MGD) 
 
Short Title - MGD 
 
Ho Sik Hwang, Geraint J. Parfitt, Donald J. Brown, James V. Jester 
 
Gavin Herbert Eye Institute, University of California Irvine, Irvine, California. 
 
Correspondence:  
James V. Jester, PhD, 843 Health Sciences Road, University of California, Irvine, 
Irvine, CA 92697-4390. Email: JJester@uci.edu 
 
Support in part by: 
NEI EY021510, the Skirball Program in Molecular Ophthalmology, Research to 
Prevent Blindness, Inc. 
 
Key Words 
 Meibomian gland, Dry Eye, Ocular Surface, Meibocyte, PPARgamma, Stem Cell. 
 
Hwang et al 
MGD 
Page 2 
Abstract 
 This paper reviews our current understanding of age-related meibomian gland 
dysfunction (MGD) and the role of the nuclear receptor, peroxisome proliferator-
activated receptor gamma (PPARγ), in the regulation of meibomian gland function, 
meibocyte differentiation and lipid synthesis.  The studies suggest that PPARγ is a 
master regulator of meibocyte differentiation and function, whose expression and 
nuclear signaling coupled with meibocyte renewal is altered during aging, potentially 
leading to atrophy of the meibomian gland as seen in clinical MGD.  Study of 
meibomian gland stem cells also suggest that there is a limited number of precursor 
meibocytes that provide progeny to the acini, that may be susceptible to exhaustion as 
occurs during aging and other environmental factors.  Further study of pathways 
regulating PPARγ expression and function as well as meibocyte stem cell maintenance 
may provide clues to establishing cellular and molecular mechanisms underlying MGD 
and the development of novel therapeutic strategies to treating this disease.  
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1. Introduction 
 Meibomian glands are holocrine, sebaceous-like glands in the upper and lower 
eyelid that excrete lipid (meibum) onto the surface of the eye to form the lipid layer of 
the tear film that reduces tear evaporation (Mishima and Maurice, 1961; Nicolaides et al., 
1981).  Dysfunction of the meibomian glands (MGD) as assessed by gland dropout and 
meibum quality, is a common eyelid disorder having widespread prevalence in the US 
population with the incidence increasing with age (Hom et al., 1990; Lemp and Nichols, 
2009; Ong, 1996; Ong and Larke, 1990).  MGD is also thought to be a major cause of 
evaporative dry eye disease (EDED) (Mathers and Lane, 1998), with loss of glands 
and/or altered meibum resulting in decreased tear film lipid, increased aqueous tear 
evaporation (Mishima and Maurice, 1961), and increased tear film osmolarity (Gilbard et 
al., 1989); leading to ocular surface changes, unstable tear film and blepharitis 
(McCulley and Shine, 2003; Shimazaki et al., 1995).  
 The proposed pathogenic mechanism underlying the most common form of MGD 
is thought to involve obstruction of the meibomian gland by hyperkeratinization of the 
ductal epithelium leading to blockage of the meibomian gland orifice, stasis of the gland, 
cystic dilatation and then atrophy of the holocrine, excretory acini (Foulks and Bron, 
2003; Knop et al., 2011).  Recent studies from our laboratory suggest that alternative 
pathways involving aging and stem cell exhaustion mediated by environmental stress 
may also play important roles in the development of meibomian gland dropout and 
altered meibum secretion. In this review article, we will present our latest understanding 
of the effects of aging, environmental stress and stem cell renewal on meibomian gland 
function with the goal of rethinking the pathogenesis of MGD and EDED as well as 
propose new treatments based on these new concepts.  
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2. Effects of Age on Human Meibomian Glands 
 Aging has long been recognized as a contributing factor to the development of 
MGD (Hom et al., 1990; Hykin and Bron, 1992).  While past work has primarily focused 
on the effects of hormones in contributing to these changes (Sullivan et al., 2006; 
Sullivan et al., 2002), little is known about how aging effects acinar meibocyte 
differentiation, lipid synthesis and function. In a study using excess surgical eyelid tissue 
from patients ranging in age from 18-95 years, we identified altered expression of the 
lipid sensitive, nuclear receptor, peroxisome proliferator-activated receptor gamma 
(PPARγ) (Nien et al., 2011).  PPARγ is a member of closely homologous genes 
ubiquitously expressed in various tissues, and is the major subtype expressed in 
adipocytes and sebocytes, where it regulates the expression of genes involved in 
lipogenesis (Rosen et al., 1999; Rosen and Spiegelman, 2001).  Using 
immunocytochemistry, PPARγ appears to be highly expressed in meibomian gland 
acinar cells/meibocytes, showing a distinct cytoplasmic and nuclear localization in tissue 
samples from youngest patients (ages, 18 and 44 years) (Figure 1A). Interestingly, older 
individuals (>60 years) showed predominantly nuclear staining, with cytoplasmic 
staining limited to the basal acinar cells in 17 of 31 subjects (Figure 1B). Using 
antibodies against the nuclear antigen, Ki67 that labels actively cycling cells (Petroll et 
al., 1998), the number of positively stained basal acinar cells were significantly higher in 
meibomian glands from the younger compared with older subjects based on linear 
regression analysis (r2=0.35; P<.001) (Figure 1C and 1D). Together, these results 
indicate that aging human meibomian glands show both decreased meibocyte 
differentiation as identified by decreased and altered PPARγ expression and decreased 
meibocyte cell renewal as identified by Ki67 staining.  These two findings suggest that 
the development of age-related MGD may involve altered PPARγ signaling and/or loss 
of stem cell renewal leading to acinar atrophy and development of an age-related MGD. 
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3. Mouse as a Model for Age-Related MGD 
 During development mouse meibomian gland morphogenesis begins after eyelid 
fusion with the formation of regularly spaced epithelial placodes within the fused 
epithelium at embryonic day 18.5, which is followed by invasion of the epithelium into 
the underlying mesenchyme to form the presumptive meibomian gland duct (Nien et al., 
2010). The first appearance of PPARγ expression and lipid synthesis begins at 
postnatal day 3 (PN3), both localized to the nascent lumen of the duct.  Nascent acini 
first appear at PN5, showing both PPARγ expression and lipid synthesis.  Fully 
developed meibomian glands with normal expression patterns for PPARγ are detected 
by PN15. Western blotting of meibomian gland proteins also detects a 50 kD protein 
that is the expected molecular weight of PPARγ, as well as a 72 kD band that is 
presumably a post-translationally modified PPARγ product.  Overall, these findings 
indicate that meibomian gland development has distinct similarities to hair follicle 
development with the formation of an epithelial placode (Fuchs, 2007), and that PPARγ 
may play an important role in meibomian gland morphogenesis, function and meibocyte 
differentiation, with expression of PPARγ preceding formation of meibomian gland acini.  
 As the adult mouse ages, changes in PPARγ expression and meibocyte renewal 
in the meibomian gland that parallel changes seen in human meibomian glands are also 
detected (Nien et al., 2009).  In evaluating eyelid tissue obtained from C57Bl/6 mice at 2, 
6, 12 and 24 months of age, meibomian glands from younger mice (2 and 6 months) 
show cytoplasmic and nuclear PPARγ staining with abundant Oil Red O staining (Figure 
2, A and B), as contrasted by the loss of cytoplasmic PPARγ staining seen in 
meibomian glands of older mice (12 and 24 months) that also show less ORO staining 
(Figure 2, C and D). Interestingly, aging also leads to a significant loss of proliferative 
potential within the meibomian gland acini that can be detected by Ki67 labeling 
(P<.004), as well as a significant decrease in the size of the meibomian glands (P<.04) 
suggesting an age-related gland atrophy.  
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 Age-related changes in PPARγ receptor signaling have also been studied by 
western blotting (Jester et al., 2016).  When meibomian gland tissue extracts from 
young mice (2 months old) were separated into the cytoplasmic and nuclear fraction 
and probed for PPARγ expression, the cytoplasmic fraction contained both the 50 kD 
native protein and 72 kD post translationally modified protein, while the nuclear fraction 
contained only the 50 kD isoform.  By comparison, meibomian gland extracts from old 
mice (2 years old) showed a significant 100% loss of the 50 kD, a significant 75% loss 
of 72 kD cytoplasmic PPARγ (P<.05), and a significant 40% decrease in the 50 kD 
nuclear PPARγ (P<.05).  Together these finding confirm the immunocytochemical 
findings and show that the PPARγ receptor is significantly down-regulated with age, 
suggesting a significant loss of lipid synthesis. 
 Overall, these findings indicate that there is altered PPARγ receptor signaling in 
older mice that parallel changes in meibocyte renewal and lipid synthesis that is 
associated with age-related MGD in humans. Furthermore, the similarity in the age-
related findings for human and mouse suggest that the mouse model may be a valuable 
tool in understanding the effects of age on meibomian gland function, as well as 
identifying the underlying mechanism of age-related MGD.   
 
4. Absence of ductal hyper‐ keratinization in Mouse age‐ related MGD 
 Because age-related MGD in the mouse and human both lead to acinar atrophy 
and loss of the meibomian glands, we have investigated the role of hyperkeratinization 
in the development of age-related MGD in mouse as hyperkeratinization is putatively 
the most common pathway leading to acinar atrophy and meibomian gland dropout 
(Foulks and Bron, 2003; Knop et al., 2011).  For a part of these studies we have 
developed a novel imaging approach, Immunofluorescent Computed Tomography (ICT), 
to localize and quantify multiple biomarkers of cell differentiation and function in large 
tissue volumes at high resolution (Parfitt et al., 2012).  ICT uses computer 
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reconstruction of serial sectioned and sequentially immunostained butyl-methyl 
methacrylate (BMMA) embedded tissue (Figure 3). Using ICT we have 3-dimensionally 
reconstructed the murine lower eyelid that contains the meibomian gland and localized 
cell nuclei (DAPI), Ki67 and cytokeratin (CK) 1, 5 and 6 to assess cell density, cell 
proliferation, gland keratinisation and gland volume.  
 In reconstructions of 5-month and 2-year old mouse eyelids, we detected a 
dramatic decrease in gland size, combined with a loss of ductal, acinar and lipid volume 
in old meibomian glands (Jester et al., 2011; Parfitt et al., 2013).  Using 
immunocytochemistry to localize cytokeratin biomarkers for keratinization (CK1) and 
non-keratinized stratified epithelium (CK6) (Figure 4), we detected extension of CK1 
from the skin epidermis into the orifice of the meibomian gland in young mice, with 
continued immunostaining posterior to the orifice where it abruptly stopped at the 
mucocutaneous junction (MCJ) and was replaced by CK6 stained conjunctival 
epithelium.  CK1 staining also abruptly stopped at the orifice of the gland, where it was 
replaced again by CK6 stained meibomian gland ductal epithelium.  In old mouse 
meibomian glands, CK1 staining from the skin epidermis extended up to the anterior 
border of the orifice, but did not extend posteriorly, indicating that the MCJ had been 
displaced anteriorly, and that the lid margin was less, not more, keratinized. CK1 
staining also did not appear to extend any deeper into the duct of the gland.  
Interestingly, epithelial plugs were detected in old meibomian glands, but these plugs 
were comprised of CK5 and CK6 immunostained epithelial cells, not CK1.   
 Overall, these findings support the premise that hyperkeratinization leading to 
gland obstruction does not play a role in the development of age-related MGD in the 
mouse.  Additionally, the anterior displacement of the MCJ in old mouse eyelids 
appears to mimic the anterior displacement of the MCJ, clinically identified as Marx line, 
observed in aging humans (Bron et al., 2011a, b; Yamaguchi et al., 2006).  Since there 
is a strong correlation between the anterior displacement of the MCJ and the 
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development of clinical MGD (Yamaguchi et al., 2006), these findings also bring into 
question the role of hyperkeratinization in the development of human MGD (Jester et al., 
2015).   
 To further evaluate the role of keratinisation in meibomian gland function we 
have identified the gene expression patterns of young and old mouse meibomian glands 
by performing a transcriptome analysis using RNA sequencing (Parfitt et al., 2016a).  
The results of differential gene expression data indicated that 18 genes were 2 fold 
enriched in meibomian glands of young male and female mice while 151 genes were 
enriched in old meibomian glands.  Of genes showing significant differences, a number 
of pathways were identified by GO ontology involving genes known to be associated 
with PPARγ function that were decreased in old tissue.  Of particular interest was the 
finding that there was no significant difference in the expression of keratinisation genes, 
including CK 1 and CK10 as well as cornified envelope proteins, Sprr1a and Sprr2a, 
that are necessary for keratinization.  Together, these findings support our 
immunocytochemical and biochemical findings indicating that PPARγ signaling is 
significantly altered in age-related MGD, and that obstruction due to hyperkeratinization 
plays little, if any, role. 
 
5. PPARγ Control of Mouse Meibocyte Differentiation 
 To begin to understand the role of PPARγ in regulating meibomian gland function, 
we developed an immortalized mouse meibocyte cell line using a SV40 lentiviral vector 
(Jester et al., 2016).  Lipid synthesizing clones were tested for effects of PPAR agonist, 
rosiglitazone, on lipid synthesis and PPARγ localization, post translational modification 
and induction of PPARγ response genes.  Cultured meibocytes produced neutral lipid 
containing equal amounts of wax and cholesterol esters, similar to mouse meibum. 
Addition of rosiglitazone (10-50 μM) produced a significant 8-9 fold increase in neutral 
lipid accumulation by meibocytes in culture (P<.05).  Increased lipid synthesis was also 
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associated with a significant accumulation of cytoplasmic 50 kD and 72 kD PPARγ.   
Furthermore, immunoprecipitation and western blotting detected sumoylation of PPARγ 
by SUMO1 indicating that the 72 kD PPARγ was indeed a post translational 
modification of PPARγ that was associated with receptor signaling and lipid synthesis in 
meibocytes. Rosiglitazone also up-regulated mRNA for PPARγ, adiponectin and 
adipocyte differentiation related protein, all genes that are important in adipocyte 
differentiation and lipid synthesis. Overall these findings support the premise that 
PPARγ signaling regulates lipid synthesis of meibocytes, and that the loss of 
cytoplasmic/vesicular PPARγ localization in older, atrophic mouse meibomian glands 
and potentially older human meibomian glands indicates that there is a loss in the ability 
of meibomian glands to synthesize and secrete meibum, suggesting a loss in meibocyte 
differentiation.  
 
6. Effect of Desiccating Stress on Mouse Meibomian Gland Function 
 Over the past decade a mouse model of low humidity environmental stress has 
become widely popular for assessing the underlying mechanism of ocular surface 
inflammation associated with dry eye (Stern et al., 1998a, b).  While studies have 
focused on changes in the conjunctival and corneal ocular surface, we have recently 
evaluated the changes in the meibomian gland of mice exposed to this environmental 
stress (Suhalim et al., 2014).  In our study, low humidity stress caused a 3-fold increase 
in basal acinar cell proliferation from 18.3 ±11.1% in untreated mice to 64.4 ± 19.9% 
and 66.6 ± 13.4% after 5 and 10 days exposure, respectively (P < .001) (Figure 5). 
Since the meibomian gland is a holocrine gland, in which cells undergo differentiation 
and disintegration to release lipid, the increase proliferation suggests an increase in 
meibocyte renewal compensatory to the increase disintegration and release of lipid into 
the meibomian gland duct.  This increased release was also suggested by dilation of the 
duct as shown in Figure 5.   
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 To assess changes in lipid quality, stimulated Raman scattering (SRS) 
microscopy was used to image vibrational signals from specific chemical bonds 
associated with protein (amide I) and lipid (CH2).  SRS is a nonlinear optical technique 
that is non-destructive and non-invasive and can be used to identify specific chemical 
vibrational signals in cells, tissues or tissue sections that can later be stained to more 
precisely localize chemical patterns, particularly cells (Lin et al., 2011). Using SRS to 
probe tissue sections from normal eyelids we have shown that acinar regions of the 
gland all have a high protein to lipid ratio that gradually decreased moving from the 
ductule to the central duct to the orifice of the gland.  This finding suggests that lipid 
synthesized by the meibomian glands undergoes a maturation process where protein is 
gradually and continually removed from the lipid prior to exiting the orifice of the gland.  
Meibomian glands from mice exposed to desiccating stress showed no decrease from 
acini to central duct, and in some cases showed increased protein suggesting that 
increased cell proliferation and cell turnover induced by the environmental stress may 
lead to abnormal or altered meibocyte differentiation and retention of protein in the lipid 
prior to secretion from the gland.  Retention of protein most likely would have a 
profound effect on the lipid quality and fluidity.  Recent studies assessing the surface 
pressure of meibomian gland lipids expressed from normal human subjects using a 
Lagmuir trough indicate that incorporation of purified keratin proteins into human 
meibum increased the surface pressure above that of meibum alone (Palaniappan et al., 
2013).  The authors postulate that a 10% increase in keratin proteins as reported by 
Ong et al for MGD subjects (Ong et al., 1991) would make the lipid more rigid and 
subject to fracture if incorporated into the lipid layer of the tear film. 
 These data are consistent with a model that a environmental stress may have a 
direct effect on meibomian gland function, leading to a significant increase in basal 
acinar cell proliferation, abnormal meibocyte differentiation, and altered lipid production. 
Not only may environmental stress lead to changes in lipid quality, but continual or 
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repeated exposure may potentially effect meibocyte renewal by depleting meibocyte 
stem cells and lead to early aging changes and gland atrophy. 
 
7. Meibomian Gland Stem cells  
 Until recently, the location and characterization of meibomian gland stem cells 
was controversial with Lavker et al suggesting that stem cells were located along the 
central duct, similar to the location of hair follicle stem cells along the hair follicle 'bulge' 
region (Lavker et al., 2003), and Olami et al suggesting that stem cells were located at 
the interface between the acinar and ductal basal cells (Olami et al., 2001). To address 
this question, we used the H2B-GFP/K5tTA ‘tet-off’ transgenic mouse to initially label 
proliferating cells with nuclear GFP and then follow labeled cells after tetracycline 
treatment to turn-off nuclear GFP expression (Parfitt et al., 2015).  ICT was then used to 
identify, localize and quantify the label retaining cells (LRCs) at different intervals after 
tetracycline treatment.  In our study, there was a rapid loss of GFP labeled cells due to 
either dilution (continued proliferation to dilute nuclear label) or differentiation and 
disintegration.  By 28 days after tetracycline treatment, there were on average only 
25±4 GFP labeled cells within individual meibomian glands, located at the interface 
between the acini and the ductal epithelium.  The number of GFP labeled cells 
continued to decline over time to 12±2 and  9±3 LRCs at 48 and 56 days after treatment. 
with all LRCs observed at the interface between CK6+ ductal epithelium and CK6-
/PPARγ+ acinar basal epithelium of the meibomian gland.  Additionally, LRCs in the 
meibomian gland were exclusively SOX9+ and BLIMP1-, putative sebocyte progenitor 
markers, however both SOX9+ and BLIMP1+ differentiated ductal and acinar epithelial 
cells could also be detected. Overall, these data suggest that meibomian gland stem 
cells are located at the interface between the ductal and acinar basal epithelium 
 Since meibocytes rapidly transit through the acinus, migrating from the basal 
compartment to the disintegrating compartment within 9 days (Olami et al., 2001), 
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continuous basal meibocyte renewal is critical to normal meibomian gland function.  To 
begin to understand this process we have used lineage tracing to better assess the 
origin and number of stem cell that participate in this process (Parfitt et al., 2016b).  For 
these studies we have used K14CreERT2-Confetti mouse, which express the conditional 
Brainbow 2.1 allele which incorporates open reading frames for membrane-bound 
mCerulean (CFP), nuclear GFPII (GFP), cytoplasmic monomeric enhanced yellow 
fluorescent protein (YFP) and tdimer2(12) (RFP) (Amitai-Lange et al., 2015; Di Girolamo 
et al., 2015).  When Confetti mice are crossed with tamoxifen-activable K14CreER mice, 
ten possible recombination’s of the four fluorescent proteins can occur within a single 
dividing cell that is K14+.  Since progeny of these cells are uniquely marked, lineage 
tracing can be performed to determine the fate of progenitor cells/stem cells that are 
responsible for meibocyte renewal.  As shown in Figure 6, meibomian glands from 
Confetti mice show unique cell populations that can be identified by the differential 
expression of fluorescent tags controlled by the brainbow cassette.  Interestingly, the 
meibomian gland duct appears to be comprised of cells from multiple origins, while cells 
within a single acinus appear to be derived from the same cell.  It was also interesting to 
note that there was no labeling of ductal epithelium adjacent to labeled acini, indicating 
that the cells giving rise to meibocytes were uni-potential. These finding suggests that 
acini are derived from a single stem cell, that once depleted could result in acinar 
atrophy and dropout.  By comparison, the duct is renewed by multiple progenitor cells of 
different origin.  These new findings, coupled with our earlier observations suggest the 
hypothesis that meibomian gland LRC/stem cells may have two different stem cell 
populations that give rise independently to both ductal epithelium and acinar meibocytes.  
Since acinar stem cells are localized to sites of individual acini, it is possible that 
exhaustion of these stem cells lead to loss of individual acini, and meibomian gland 
dropout as seen in clinical MGD.  
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8. New pathogenesis of meibomian gland dysfunction 
 The most commonly recognized mechanism for the development of MGD has 
been a 'ductal centric' hypothesis involving epithelial hyperkeratinization causing 
obstruction of meibomian orifice, stasis of meibum, and cystic dilation of the duct that 
leads to a secondary, disuse acinar atrophy and gland dropout (Knop et al., 2011). By 
contrast, our studies suggest a 'meibocyte centric' hypothesis involving mechanisms 
that regulate differentiation and renewal of meibocytes that may directly impact meibum 
quality, lipid synthesis and acinar atrophy without confounding changes in the ductal 
epithelium.  A key finding in support of this alternative hypothesis has been the 
observation of altered PPARγ receptor localization and expression in older individuals 
and animal models.  Our studies have shown that PPARγ is expressed as early as PN3 
during meibomian gland development, and is perhaps responsible for both the formation 
of the ductal lumen as well as the differentiation of epithelia to a meibocyte phenotype 
at PN5.  Furthermore, the changes in PPARγ expression detected in aging individuals 
suggest a loss of differentiation and ability to synthesize lipid, as evidenced by both the 
decreased 50 kD PPARγ in the nucleus and cytoplasm, and the loss of the 72 kD 
PPARγ that is a post translational modification associated with active lipid synthesis.  
Since these changes appear to occur in the absence of hyperkeratinization and ductal 
dilation, it is not likely that the observed changes in PPARγ signaling are the result of a 
'disuse atrophy' as proposed for obstructive MGD.  Rather, it is more likely that factors 
regulating PPARγ receptor expression and function play the central role.  
 Unfortunately, little is known regarding the molecular pathways controlling 
PPARγ-regulated meibocyte differentiation.  Some possible factors that may influence 
this pathway are presented in Figure 7.  In particular aging and undefined age-related 
factors may clearly play a role, since our experimental findings are common in older 
individuals and animals.  Additionally, increased tear evaporation associated with low 
humidity and increased airflow also leads to increased meibocyte proliferation, 
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differentiation and altered lipid synthesis, suggesting that a range of environmental 
stress responses may effect meibocyte differentiation, including contact lens wear, long 
known to cause MGD (Henriquez and Korb, 1981; Korb and Henriquez, 1980), 
prolonged blinking intervals associated with video display terminal usage and reading 
(Fenga et al., 2008), and low humidity environments (McCulley et al., 2006).  Hormonal 
factors are also known to be associated with ocular surface disease and thought to be 
involved in the development of MGD (Sullivan et al., 2006; Sullivan et al., 2002).  
Dietary factors also influence meibomian gland differentiation, as recently shown in the 
Hairless mouse fed on a limited lipid diet contain low amounts of lipids known to be 
PPARγ agonists (Miyake et al., 2016).  Neurogenic factors, while little studied, are likely 
to play an important role since the meibomian gland is highly innervated, unlike their 
counterpart, the sebaceous gland (Kam and Sullivan, 2011; Kirch et al., 1996).  Finally, 
recent studies indicate that inflammation and allergy may have marked effects on 
meibomian gland function leading to plugging, ductal dilation and gland hypertrophy 
(Reyes and Saban, 2016).  that little is known of the effect of inflammation and inflamma 
 A second pathway leading to altered meibocyte function is suggested by the 
finding of a limited number of meibomian gland LRC, suggesting a limited stem cell 
population.  The additional finding that acini are renewed by a single stem cell adjacent 
to individual acini, further suggest that stem cell exhaustion or depletion may play an 
important role in the loss of acini due to age.  Our finding that environmental factors 
may influence the proliferative rate of meibocytes, also suggest that early stem cell 
depletion may underlie meibomian gland dropout and acinar atrophy in younger 
individuals.  There are only a handful of studies that have evaluated meibomian gland 
stem cells, and little is known about control of meibomian gland stem cell fate and 
survival.  Nevertheless, similar factors influencing meibocyte differentiation as 
presented in Figure 7, may also play a role in stem cell maintenance as discussed 
above.   
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9. Future Direction and Therapeutic Strategies  
 Clearly, a better understanding of the cellular and molecular pathways regulating 
meibomian gland function and meibocyte differentiation are needed to help establish a 
clearer mechanistic foundation for the development and progression of MGD.  The 
recent establishment of a telomerized human meibomian gland epithelial cell line will 
undoubtedly help toward the discovery of some of these pathways (Liu et al., 2010).  
Additionally, better models of MGD in mice are needed to validate putative pathways 
and understand the relationship between meibomian gland function, meibocyte 
differentiation and ocular surface integrity and disease.  Such models, both in vitro and 
in vivo, will also help in the discovery of new therapies that may restore meibomian 
gland function and/or reverse pathologic changes leading to ocular surface disease.  
Some potential targets are suggested by our studies of PPARγ, and include agonist, 
such as Rosiglitazone or other drugs currently used in diabetes, that stimulate PPARγ 
receptor signaling and induce lipid synthesis and potentially meibocyte differentiation.  
Understanding the effects of upstream regulators of PPARγ and how they influence 
PPARγ signaling may also lead to the development of new approaches to treating MGD.  
Finally, a fuller understanding of meibocyte renewal and the maintenance of meibocyte 
stem cells may have a dramatic impact on our ability to maintain meibomian gland 
function in patients that show marked loss of meibomian glands as well as regenerate 
meibomian glands and acini to replace lost tissue.   
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